A new research has disclosed that the popular heart drug Statins can raise diabetes risk.

In the new study, Statins, which is helpful in lowering cholesterol, has been shown to increase diabetes possibility by 8% in people in their 60s.

As per the meta-analysis, merging the outcomes of 13 examinations, for every individual who developed diabetes, five would have kept coronary failure or heart problem at bay thanks to the pills.

But, the scientists said that they do not make out why the drugs might lead to diabetes or if it is simply down to chance.

The appraisal, by a group from the University of Glasgow, involved over 90,000 patients. More than 4 years, 4,278 had diabetes and 2,226 of these had been suggested statins.

The group thought that for every 255 sufferers having statins over 4-years there will be one additional case of polygenic disease.

Writing in the Lancet, Lead researcher Dr. David Preiss of Glasgow Cardiovascular Research Centre stated, "In view of the overwhelming benefit of statins for reduction of cardiovascular events, the small absolute risk for development of diabetes is outweighed by cardiovascular benefit in the short and medium term in individuals for whom statin therapy is recommended."

"We therefore suggest that clinical practice for statin therapy does not need to change for patients with moderate or high cardiovascular risk or existing cardiovascular disease."

"However, the potentially raised diabetes risk should be taken into account if statin therapy is considered for patients at low cardiovascular risk or patient groups in which cardiovascular benefit has not been proven.," Dr. David added. (With Input from Agencies)